Related Experiment Video
Updated: Dec 3, 2025
08:17
A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
9.9K
COX-2 Signaling in the Tumor Microenvironment
Yuan Zhang1, Sean Tighe1, Ying-Ting Zhu2
1Research and Development Department, Tissue Tech, Inc., Miami, FL, USA.
Advances in Experimental Medicine and Biology
|October 29, 2020
Summary
Cyclooxygenase-2 (COX-2) is crucial in the tumor microenvironment (TME), influencing cancer growth, spread, and immune evasion. Understanding COX-2 signaling in the TME is key for developing new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tumorigenesis is a complex process involving the tumor microenvironment (TME).
- The TME comprises cellular components, cell-cell interactions, and the extracellular matrix (ECM).
- Cyclooxygenase-2 (COX-2) is a key mediator of TME alterations in cancer.
Purpose of the Study:
- To review recent research on COX-2 signaling within the TME.
- To highlight the role of COX-2 in various aspects of cancer progression.
Main Methods:
- Literature review of studies investigating COX-2 signaling in the TME.
- Synthesis of findings on COX-2's functional roles in cancer.
Main Results:
- COX-2 is frequently overexpressed in numerous cancer types.
- COX-2 promotes tumor cell proliferation, invasion, and metastasis.
- COX-2 inhibits apoptosis, suppresses anti-tumor immunity, and supports angiogenesis.
Conclusions:
- COX-2 plays a significant role in modulating the TME.
- Targeting COX-2 signaling in the TME offers potential therapeutic strategies for cancer treatment.
Keywords:
AngiogenesisApoptosisArachidonic acidCell growthCyclooxygenase-2ImmunityInvasionMetastasisMicroenvironmentNSAIDProstaglandinRegulationStructureTumorTumorigenesisMore Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.9K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.2K
Related Concept Videos
02:17The Tumor Microenvironment
7.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
03:03mTOR Signaling and Cancer Progression
4.4K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.4K
01:19Interactions Between Signaling Pathways
7.0K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
02:07Tumor Progression
7.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
01:16TGF - β Signaling Pathway
9.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.7K
01:41Non-Canonical Wnt Signaling Pathways
8.0K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.0K